Our previous study reported that EIF4G1 was significantly up‐regulated in NSCLC cell lines compared to normal lung cells, which makes these lung cancer cells more susceptible to EIF4G1‐targeted therapy.16, 17. This evidence concerns the gene EIF4G1 and non-small cell lung carcinoma.